Home›Research›Compare›GHRP-2 vs Sermorelin
Peptide ComparisonGHRP-2 vs Sermorelin
Both are GH / IGF Axis peptides.
GHRP-2
Growth Hormone Releasing Peptide 2
Half-life: 15–60 minutes
49 providers listed
Sermorelin
GHRH 1-29
Half-life: 10–20 minutes
473 providers listed
Sermorelin carries stronger published evidence (RCT, 3 key studies) than GHRP-2 (Cohort study, 2); both are research compounds.
GHRP-2
Half-life
15–60 minutes
Sermorelin
Half-life
10–20 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Sermorelin |
| Less frequent dosing (longer half-life) | GHRP-2 |
| Lower typical price per mg | GHRP-2 |
| More provider options (49 vs 473) | Sermorelin |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
GHRP-2
Sermorelin
GHRP-2
Sermorelin
The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients…
The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostat…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
About GHRP-2
Synthetic hexapeptide that stimulates pulsatile growth hormone release from the anterior pituitary by acting on the ghrelin receptor (GHSR-1a). Commonly stacked with GHRH analogs such as CJC-1295 or Sermorelin to amplify GH output synergistically.
About Sermorelin
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on pituitary somatotrophs, stimulating pulsatile GH secretion in a physiological pattern that preserves the natural hypothalamic-pituitary feedback axis — contrasting with direct GH administration. Downstream IGF-1 elevation mediates many of its body composition, tissue-repair, and sleep quality effects.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
GHRP-2
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
GHRP-2 stimulates GH and cortisol release. Research protocols measure IGF-1 for GH axis response and baseline cortisol given the compound's adrenal stimulation. Glucose markers are standard given GH's effect on insulin sensitivity.
Sermorelin
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Sermorelin clinical protocols measure IGF-1 as the primary marker of GH axis response. Fasting glucose and insulin are standard baseline assessments given GH's effect on insulin sensitivity.
GHRP-2
Corticosteroids
Research notes that GHRP-2 stimulates cortisol and ACTH release via the HPA axis. Combined use with corticosteroid medications may affect glucocorticoid regulation. Consult your prescriber before combining.
Sermorelin
Ipamorelin
Research suggests Sermorelin and Ipamorelin may produce complementary growth hormone release effects when combined. Sermorelin acts as a GHRH analogue via pituitary receptors, while Ipamorelin acts via ghrelin receptors — dual-pathway stimulation studied in GH optimization research.
GHRP-2
Sermorelin
Where to source these peptides
GHRP-2
49 listed
Browse directory →
Providers offeringSermorelin
473 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated October 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). GHRP-2 vs Sermorelin — Per-mg Price Comparison. Retrieved October 27, 2026, from https://peptidebase.io/peptides/compare/ghrp-2/sermorelin